This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Gouveri E, Papanas N. The emerging role of continuous glucose monitoring in the management of diabetic peripheral neuropathy: A narrative review. Diabetes Ther. 2022;13:931-52.Search in Google Scholar
Bönhof GJ, Herder C, Strom A, Papanas N, Roden M, Ziegler D. Emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocr Rev. 2019;40:153-92.Search in Google Scholar
Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-4.Search in Google Scholar
Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected Type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41:1068-75.Search in Google Scholar
Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, et al. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol. 2018 14;5:397-405.Search in Google Scholar
Schlesinger S, Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care. 2019;42:240-7.Search in Google Scholar
Oh TJ, Lee JE, Choi SH, Jang HC. Association between body fat and diabetic peripheral neuropathy in middle-aged adults with Type 2 diabetes mellitus: A preliminary report. J Obes Metab Syndr. 2019;28: 112-7.Search in Google Scholar
Patel GR, Samaria A, Kant C, Prajapati GR. Potential risk factors for peripheral neuropathy in patients with type 2 diabetes mellitus: a case control study from central Rajasthan. Int J Adv Med. 2022;9: 448-55.Search in Google Scholar
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40:136-54.Search in Google Scholar
Luescher T, Mueller J, Isenschmid C, Kalt J, Rasiah R, Tondorf T, et al. Neuron-specific enolase (NSE) improves clinical risk scores for prediction of neurological outcome and death in cardiac arrest patients: Results from a prospective trial. Resuscitation. 2019;142: 50-60.Search in Google Scholar
Wihersaari L, Tiainen M, Skrifvars MB, Bendel S, Kaukonen KM, Vaahersalo J, et al. FINNRESUSCI study group. Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. Resuscitation. 2019;139:214-21.Search in Google Scholar
Haque A, Ray SK, Cox A, Banik NL. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metab Brain Dis. 2016;31:487-95.Search in Google Scholar
Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: Biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125-43.Search in Google Scholar
Li J, Yan M, Zhang Y, Xie M, Yan L, Chen J. Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema. Diabet Med. 2015;32:102-7.Search in Google Scholar
Bril V, Tomioka S, Buchanan RA, Perkins BA. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med. 2009;26:240-6.Search in Google Scholar
Ibrahim AA, Baban RS, Khudair MS. Clinical and biochemical association between serum and urin level of the uromodulin protein with albuminuria in patients with type-2 diabetes mellitus. Biochem Cell Arch. 2019;19:2367-70.Search in Google Scholar
Nuttall FQ. Body Mass Index: Obesity, BMI, and health: A critical review. Nutr Today. 2015;50:117-28.Search in Google Scholar
Román-Pintos LM, Villegas-Rivera G, Rodríguez-Carrizalez AD, Miranda-Díaz AG, Cardona-Muñoz EG. Diabetic polyneuropathy in Type 2 diabetes mellitus: Inflammation, oxidative stress, and mitochondrial function. J Diabetes Res. 2016;2016:3425617.Search in Google Scholar
Albegali AA, Shahzad M, Mahmood S, Ullah MI, Amar A, Sajjad O. Genetic polymorphism of eNOS (G894T) gene in insulin resistance in type 2 diabetes patients of Pakistani population. Int J Diabetes Dev Ctries. 2020;40:203-8.Search in Google Scholar
Zhou R, Li F, Chen G, Fu Q, Gu S, Wu X. Associations between general and abdominal obesity and incident diabetic neuropathy in participants with type 2 diabetes mellitus. J Diabetes. 2021;13:33-42.Search in Google Scholar
Hunaifi I, Agustriadi IGNO, Asmara IGY, Budyono C. The correlation between HbA1c and neuropathy disability score in type 2 diabetes. Acta Med Indones. 2021;53:164-8.Search in Google Scholar
Kumar MJ, Ponnu S. Diabetic neuropathies-clinical and electrophysiological profile. Int J Heal Clin Res. 2022;5(3):769-72.Search in Google Scholar
Kandasamy S, Krishnan B, Gopalakrishnan S, Ganesan H. Serum neuron-specific enolase as a biomarker in diagnosing diabetic peripheral neuropathy: A cross-sectional study. Asian J Med Sci. 2022;13:92-6.Search in Google Scholar
Kelleher M, Singh R, O’Driscoll CM, Melgar S. Carcinoembryonic antigen (CEACAM) family members and inflammatory bowel disease. Cytokine Growth Factor Rev. 2019;47:21-31.Search in Google Scholar
, , 